{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:15:47Z","timestamp":1794917747918,"version":"4.9.1"},"reference-count":79,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,29]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Fifty years ago, people with sickle cell disease (SCD) were discouraged from becoming pregnant, but now, most should be supported if they choose to pursue a pregnancy. They and their providers, however, should be aware of the physiological changes of pregnancy that aggravate SCD and pregnancy\u2019s unique maternal and fetal challenges. Maternal problems can arise from chronic underlying organ dysfunction such as renal disease or pulmonary hypertension; from acute complications of SCD such as acute anemia, vaso-occlusive crises, and acute chest syndrome; and\/or from pregnancy-related complications such as preeclampsia, sepsis, severe anemia, thromboembolism, and the need for cesarean delivery. Fetal problems include alloimmunization, opioid exposure, fetal growth restriction, preterm delivery, and stillbirth. Before and during pregnancy, in addition to the assessment and care that every pregnant patient should receive, patients with SCD should be evaluated and treated by a multidisciplinary team with respect to their unique maternal and fetal issues.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2023020728","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T16:20:46Z","timestamp":1700324446000},"page":"769-776","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":25,"title":["How I treat sickle cell disease in pregnancy"],"prefix":"10.1182","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4570-6595","authenticated-orcid":false,"given":"Andra H.","family":"James","sequence":"first","affiliation":[{"name":"1Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Duke University, Durham, NC"},{"name":"2Division of Hematology, Department of Medicine, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0341-1457","authenticated-orcid":false,"given":"John Joseph","family":"Strouse","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Department of Medicine, Duke University, Durham, NC"},{"name":"3Division of Hematology\/Oncology, Department of Pediatrics, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2024022916263790300_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3324\/haematol.10937","article-title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","volume":"92","author":"Telfer","year":"2007","journal-title":"Haematologica"},{"issue":"17","key":"2024022916263790300_bib2","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"issue":"23","key":"2024022916263790300_bib3","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024022916263790300_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes","volume":"221","author":"Brosens","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2024022916263790300_bib5","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.ajog.2008.04.016","article-title":"Morbidity associated with sickle cell disease in pregnancy","volume":"199","author":"Villers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"4 suppl","key":"2024022916263790300_bib6","doi-asserted-by":"crossref","first-page":"S542","DOI":"10.1016\/j.amepre.2009.12.020","article-title":"Sickle cell disease and pregnancy outcomes: women of African descent","volume":"38","author":"Barfield","year":"2010","journal-title":"Am J Prev Med"},{"issue":"4","key":"2024022916263790300_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1515\/jpm-2013-0275","article-title":"Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births","volume":"42","author":"Alayed","year":"2014","journal-title":"J\u00a0Perinat Med"},{"issue":"2","key":"2024022916263790300_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10995-012-1216-3","article-title":"Sickle cell disease in pregnancy: maternal complications in a Medicaid-enrolled population","volume":"17","author":"Boulet","year":"2013","journal-title":"Matern Child Health J"},{"issue":"5","key":"2024022916263790300_bib9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"21","key":"2024022916263790300_bib10","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","article-title":"Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis","volume":"125","author":"Oteng-Ntim","year":"2015","journal-title":"Blood"},{"issue":"23","key":"2024022916263790300_bib11","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra1213566","article-title":"Pregnancy and infection","volume":"370","author":"Kourtis","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"2024022916263790300_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.yhbeh.2012.02.023","article-title":"Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis","volume":"62","author":"Robinson","year":"2012","journal-title":"Horm Behav"},{"issue":"2","key":"2024022916263790300_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajog.2021.08.054","article-title":"An update on COVID-19 and pregnancy","volume":"226","author":"Jamieson","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2024022916263790300_bib14","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2009.03.010","article-title":"Infection in sickle cell disease: a review","volume":"14","author":"Booth","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"2","key":"2024022916263790300_bib15","doi-asserted-by":"crossref","first-page":"e2254552","DOI":"10.1001\/jamanetworkopen.2022.54552","article-title":"Severe maternal morbidity and mortality in sickle cell disease in the National Inpatient Sample, 2012-2018","volume":"6","author":"Early","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2024022916263790300_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14767050500072722","article-title":"Normal pregnancy is characterized by systemic activation of the complement system","volume":"17","author":"Richani","year":"2005","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"2024022916263790300_bib17","first-page":"429","article-title":"Leukocytes of normal pregnant women","volume":"23","author":"Efrati","year":"1964","journal-title":"Obstet Gynecol"},{"key":"2024022916263790300_bib18","doi-asserted-by":"crossref","first-page":"2040620720955000","DOI":"10.1177\/2040620720955000","article-title":"Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease","volume":"11","author":"Osunkwo","year":"2020","journal-title":"Ther Adv Hematol"},{"issue":"12","key":"2024022916263790300_bib19","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.3324\/haematol.2017.174201","article-title":"In\u00a0vitro evidence of complement activation in patients with sickle cell disease","volume":"102","author":"Gavriilaki","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"2024022916263790300_bib20","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ajh.25742","article-title":"Complement activation in sickle cell disease: dependence on cell density, hemolysis and modulation by hydroxyurea therapy","volume":"95","author":"Roumenina","year":"2020","journal-title":"Am J Hematol"},{"issue":"3","key":"2024022916263790300_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0308-2261(21)00496-3","article-title":"Blood volume changes in normal pregnancy","volume":"14","author":"Hytten","year":"1985","journal-title":"Clin Haematol"},{"issue":"6","key":"2024022916263790300_bib22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/01443610903003175","article-title":"Outcome of pregnancy in sickle cell disease patients attending a combined obstetric and haematology clinic","volume":"29","author":"Yu","year":"2009","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"5","key":"2024022916263790300_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00404-009-1002-7","article-title":"Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital, Eastern Saudi Arabia","volume":"280","author":"Al Jama","year":"2009","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"2024022916263790300_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/tme.12447","article-title":"Transfusion for sickle cell disease in pregnancy: a single-centre survey","volume":"28","author":"Sharif","year":"2018","journal-title":"Transfus Med"},{"issue":"12","key":"2024022916263790300_bib25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy","volume":"130","author":"Sanghavi","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"2024022916263790300_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2024022916263790300_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201401-0065ST","article-title":"An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease","volume":"189","author":"Klings","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2024022916263790300_bib28","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/AOG.0000000000003243","article-title":"ACOG practice bulletin no. 212: pregnancy and heart disease","volume":"133","author":"American College of Obstetricians and Gynecologists' Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins\u2014Obstetrics","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2024022916263790300_bib29","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/AOG.0000000000003256","article-title":"Chronic kidney disease and pregnancy","volume":"133","author":"Hui","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2024022916263790300_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.hoc.2022.08.009","article-title":"Sickle cell disease and the kidney: filters gone awry","volume":"36","author":"Lebensburger","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2024022916263790300_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy","volume":"16","author":"Bremme","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"2024022916263790300_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"Hellgren","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"2024022916263790300_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism during pregnancy or the puerperium: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"5","key":"2024022916263790300_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/AOG.0000000000000230","article-title":"Postpartum venous thromboembolism: incidence and risk factors","volume":"123","author":"Tepper","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"8","key":"2024022916263790300_bib35","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ajh.25508","article-title":"High incidence of venous thromboembolism recurrence in patients with sickle cell disease","volume":"94","author":"Brunson","year":"2019","journal-title":"Am J Hematol"},{"issue":"12","key":"2024022916263790300_bib36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1471-0528.1995.tb10900.x","article-title":"Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome","volume":"102","author":"Howard","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"2024022916263790300_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejogrb.2010.05.022","article-title":"Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions","volume":"152","author":"Ng\u00f4","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"2024022916263790300_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/14767058.2014.928855","article-title":"Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes","volume":"28","author":"Costa","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"11","key":"2024022916263790300_bib39","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/ajh.27045","article-title":"Pregnancy-related thromboembolism in women with sickle cell disease: an analysis of National Medicaid Data","volume":"98","author":"Agarwal","year":"2023","journal-title":"Am J Hematol"},{"issue":"4","key":"2024022916263790300_bib40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/AOG.0000000000004559","article-title":"Iron deficiency anemia in pregnancy","volume":"138","author":"James","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2024022916263790300_bib41","doi-asserted-by":"crossref","first-page":"e2254545","DOI":"10.1001\/jamanetworkopen.2022.54545","article-title":"Comparisons of severe maternal morbidity and other adverse pregnancy outcomes in pregnant people with sickle cell disease vs anemia","volume":"6","author":"Early","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2024022916263790300_bib42","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1542\/peds.2006-2768","article-title":"The mechanisms of low birth weight in infants of mothers with homozygous sickle cell disease","volume":"120","author":"Thame","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"2024022916263790300_bib43","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2024022916263790300_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tmrv.2018.07.003","article-title":"Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review","volume":"33","author":"Fasano","year":"2019","journal-title":"Transfus Med Rev"},{"issue":"4","key":"2024022916263790300_bib45","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/bjh.17983","article-title":"Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK","volume":"196","author":"Oakley","year":"2022","journal-title":"Br J Haematol"},{"issue":"1","key":"2024022916263790300_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/AOG.0000000000004986","article-title":"Association of sickle cell disease with severe maternal morbidity","volume":"141","author":"Ha","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2024022916263790300_bib47","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/1471-0528.13786","article-title":"Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis","volume":"123","author":"Boafor","year":"2016","journal-title":"BJOG"},{"issue":"11","key":"2024022916263790300_bib48","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archpedi.1994.02170110042007","article-title":"The influence of infant and maternal sickle cell disease on birth outcome and neonatal course","volume":"148","author":"Brown","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"2024022916263790300_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejogrb.2013.04.013","article-title":"Fetal growth in women with homozygous sickle cell\u00a0disease: an observational study","volume":"170","author":"Thame","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"2024022916263790300_bib50","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/01.AOG.0000127433.23611.54","article-title":"Outcome of pregnancy in homozygous sickle cell disease","volume":"103","author":"Serjeant","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"7","key":"2024022916263790300_bib51","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3109\/14767058.2011.604366","article-title":"Transient tachypnea of the newborn and congenital pneumonia: a comparative study","volume":"25","author":"Costa","year":"2011","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"6","key":"2024022916263790300_bib52","doi-asserted-by":"crossref","first-page":"100723","DOI":"10.1016\/j.ajogmf.2022.100723","article-title":"Sickle cell disease and the incidence and etiology of preterm birth","volume":"4","author":"Fashakin","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"2","key":"2024022916263790300_bib53","doi-asserted-by":"crossref","first-page":"e56541","DOI":"10.1371\/journal.pone.0056541","article-title":"Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania","volume":"8","author":"Muganyizi","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"2024022916263790300_bib54","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2024022916263790300_bib55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0039-1700865","article-title":"Neonatal Abstinence syndrome among infants born to mothers with sickle cell hemoglobinopathies","volume":"37","author":"Brown","year":"2020","journal-title":"Am J Perinatol"},{"issue":"9","key":"2024022916263790300_bib56","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1471-0528.2005.00678.x","article-title":"Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth","volume":"112","author":"Serjeant","year":"2005","journal-title":"BJOG"},{"issue":"6","key":"2024022916263790300_bib57","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4269\/ajtmh.2012.11-0625","article-title":"Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study","volume":"86","author":"Wilson","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"2024022916263790300_bib58","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"2024022916263790300_bib59","author":"Eke","year":"2022"},{"issue":"23","key":"2024022916263790300_bib60","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","article-title":"American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease","volume":"3","author":"Liem","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"2024022916263790300_bib61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00006250-200701000-00055","article-title":"ACOG practice bulletin no. 78: hemoglobinopathies in pregnancy","volume":"109","author":"ACOG Committee on Obstetrics","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2024022916263790300_bib62","first-page":"1","article-title":"NIH Consensus development statement on hydroxyurea treatment for sickle cell disease","volume":"25","author":"Brawley","year":"2008","journal-title":"NIH Consens State Sci Statements"},{"issue":"7","key":"2024022916263790300_bib63","first-page":"e30356","article-title":"Infertility and treatment-seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registry","volume":"70","author":"Stevenson","year":"2023","journal-title":"Pediatr\u00a0Blood Cancer"},{"issue":"5","key":"2024022916263790300_bib64","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajh.26495","article-title":"Pregnancy outcomes with hydroxyurea use in women with sickle cell disease","volume":"97","author":"Kroner","year":"2022","journal-title":"Am J Hematol"},{"issue":"16","key":"2024022916263790300_bib65","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/bloodadvances.2020001743","article-title":"Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects","volume":"4","author":"Kanter","year":"2020","journal-title":"Blood Adv"},{"issue":"25","key":"2024022916263790300_bib66","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024022916263790300_bib67","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3476(95)70154-0","article-title":"Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II","volume":"127","author":"Falletta","year":"1995","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"2024022916263790300_bib68","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/bjh.17671","article-title":"Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline","volume":"194","author":"Oteng-Ntim","year":"2021","journal-title":"Br J Haematol"},{"issue":"2","key":"2024022916263790300_bib69","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2024022916263790300_bib70","first-page":"849","article-title":"Pregnancy in the sickle cell disease and fetomaternal outcomes in different sickle cell genotypes: a systematic review and meta-analysis","volume":"32","author":"Aghamolaei","year":"2022","journal-title":"Ethiop J Health Sci"},{"issue":"22","key":"2024022916263790300_bib71","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM198812013192204","article-title":"Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study","volume":"319","author":"Koshy","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"2024022916263790300_bib72","first-page":"CD010378","article-title":"Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy","volume":"12","author":"Okusanya","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"2024022916263790300_bib73","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2015-06-649319","article-title":"Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis","volume":"126","author":"Malinowski","year":"2015","journal-title":"Blood"},{"issue":"11","key":"2024022916263790300_bib74","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17474086.2017.1379895","article-title":"The emerging challenge of optimal blood pressure management and hypertensive syndromes in pregnant women with sickle cell disease: a review","volume":"10","author":"Lari","year":"2017","journal-title":"Expert Rev Hematol"},{"issue":"8","key":"2024022916263790300_bib75","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","volume":"127","author":"Dumas","year":"2016","journal-title":"Blood"},{"key":"2024022916263790300_bib76","doi-asserted-by":"crossref","first-page":"e931107","DOI":"10.12659\/AJCR.931107","article-title":"Delayed severe hemolytic transfusion reaction during pregnancy in a woman with beta-thalassemia intermediate: successful outcome after eculizumab administration","volume":"22","author":"Cannas","year":"2021","journal-title":"Am J Case Rep"},{"issue":"4","key":"2024022916263790300_bib77","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1747493017743801","article-title":"Canadian stroke best practice consensus statement: secondary stroke prevention during pregnancy","volume":"13","author":"Swartz","year":"2018","journal-title":"Int J Stroke"},{"issue":"1","key":"2024022916263790300_bib78","first-page":"CD006786","article-title":"Interventions for treating painful sickle cell crisis during pregnancy","volume":"2009","author":"Marti-Carvajal","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2024022916263790300_bib79","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13063-019-3461-x","article-title":"Prevention of Morbidity in Sickle Cell Disease (POMS2a)-overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a randomised crossover pilot study examining patient preference and safety in adults and children","volume":"20","author":"Howard","year":"2019","journal-title":"Trials"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/9\/769\/2216672\/blood_bld-2023-020728-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/9\/769\/2216672\/blood_bld-2023-020728-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T16:27:25Z","timestamp":1709224045000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/143\/9\/769\/498771\/How-I-treat-sickle-cell-disease-in-pregnancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":79,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,2,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023020728","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]}}}